Histogen Inc.

OTCPK:HSTO.Q Stock Report

Market Cap: US$123.9k

Histogen Balance Sheet Health

Financial Health criteria checks 0/6

Insufficient data to determine the health of Histogen

Key information

n/a

Debt to equity ratio

n/a

Debt

Interest coverage ration/a
Cashn/a
Equityn/a
Total liabilitiesn/a
Total assetsn/a

Recent financial health updates

Analysis Article • Dec 02

We're A Little Worried About Histogen's (NASDAQ:HSTO) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Recent updates

Seeking Alpha • Aug 12

Histogen stock down 8% after Q2 loss, on track for six-day losing streak

Shares of micro-cap clinical-stage therapeutics company Histogen (NASDAQ:HSTO) fell 8% to $1.95 in Friday afternoon trading, after the company reported a quarterly loss. The stock has been on a downward trend lately and, if today's losses hold, would post a sixth straight session in the red. From the close of Aug. 4 to yesterday, it has fallen 32%. San Diego, Calif.-based HSTO is advancing three clinical programs in hair growth, dermal fillers and joint cartilage repair. HSTO after hours on Thursday posted Q2 GAAP EPS of -$1.55. The company believes its existing cash and cash equivalents and cash inflow from operations would be sufficient to meet its anticipated cash needs through Dec. 2023. It closed a $5M private financing in July.
Seeking Alpha • Jul 12

Histogen announces pricing of $5M private placement

A clinical-stage therapeutics company, Histogen (NASDAQ:HSTO) has entered into a securities purchase agreement with a single healthcare-focused institutional investor to issue 1.77M shares of common stock, Series A warrants to purchase additional 1.77M and Series B warrants to purchase up to an aggregate of 1.77M at a purchase price of $2.818 per share of common stock . Expected gross proceeds  to Histogen of ~$5M. Closing is expected to occur on or about July 15, 2022.
Analysis Article • Dec 02

We're A Little Worried About Histogen's (NASDAQ:HSTO) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Financial Position Analysis

Short Term Liabilities: Insufficient data to determine if HSTO.Q's short term assets cover its short term liabilities.

Long Term Liabilities: Insufficient data to determine if HSTO.Q's short term assets cover its long term liabilities.

Debt to Equity History and Analysis

Debt Level: Insufficient data to calculate HSTO.Q's net debt to equity ratio to determine if it is satisfactory.

Reducing Debt: Insufficient data to determine if HSTO.Q's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: Insufficient data to determine if HSTO.Q's debt is well covered by operating cash flow.

Interest Coverage: Insufficient data to determine if HSTO.Q's interest payments on its debt are well covered by EBIT.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/08 16:21
End of Day Share Price 2025/04/04 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Histogen Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John NewmanCanaccord Genuity
Douglas TsaoH.C. Wainwright & Co.